Pfizer has bolstered the evidence behind its respiratory syncytial virus (RSV) vaccine with a positive trial of the shot used to protect newborns, adding to earlier results in older adults. The ...

Inhalon Biopharma's inhaled RSV antibody treatment will enter human trials marking a potential breakthrough in respiratory ...

GSK's vaccine against respiratory syncytial virus (RSV) is one of the top prospects in its pipeline, but also one with considerable competition, so needs strong data to support the programme.

It is the highest number of cases recorded since the virus became notifiable. A free RSV vaccine will be made available to pregnant people to protect them and their unborn babies from February 3.

Over a third of women giving birth got the new RSV vaccine in September, protecting newborns from severe illness. The new maternal Respiratory Syncytial Virus (RSV) vaccine rolled out in September saw ...

A total of 16,575 laboratory-confirmed RSV-associated hospitalizations (median age, 70; women, 58.2%; White, 61.5%) were identified during the study period. Given the large numbers of potentially ...

"Looking at these numbers, knowing what is happening across the country as well as in certain jurisdictions, I think we are working certainly towards broader eligibility coverage for RSV vaccine ...

The Cyprus pulmonology society on Thursday urged Health Minister Michael Damianos to approve a respiratory syncytial virus (RSV) vaccine for use Cyprus. The society also seeks its inclusion into ...

“But also in this instance (the RSV vaccine) would be beneficial for our older patients because it would enable a reduction in the RSV cases,” Dr Raman said. “There’s a lot of expenses and ...

Sanofi executives also pointed to the company’s new RSV vaccine for newborns, Beyfortus, approved by the FDA in mid-2023. Last year, the vaccine brought in €1.7 billion ($1.77 billion) in 2024.

According to Dorgay, vaccination is again the most effective way to protect those vulnerable groups, even those under six months of age who can’t yet receive the vaccine themselves. “We recommend that ...